Research Archives - Page 4 of 5

7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

11 December 2024

CTGCT Newsletter, 1st year in review

Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year.

6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

30 August 2024

Exciting news in Sonogenetics: A New Frontier for Deep Tissue Treatment

Researchers have made a discovery that could change how we treat some diseases deep within the human body. This technique, known as sonogenetics, combines the power of ultrasound with genetically engineered cells to deliver ...

17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

1 July 2024

Panel Discussion on ATMP Regulation

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...

27 June 2024

Interview with Shivang Khandewal – collaborator of NIC and CTNNB1

Originally from India, Shivang Khandelwal is presently engaged in advanced studies at the Hebrew University of Jerusalem. His primary research focus is on PCDH19 cluster epilepsy, a neurodevelopmental and neuropsychiatric disorder. He is deeply ...

27 June 2024

Bespoke Gene Therapy Consortium – cooperation for rare disease therapies

At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ...